Jeffrey Tan

Compliance with follow-up Test of Cure and outcomes after treatment for high-grade cervical intraepithelial neoplasia in Victoria, Australia

Jeffrey HJ Tan, Michael J Malloy, Julia ML Brotherton, Marion Saville

Journal article  |  2020  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study

Jeffrey HJ Tan, Michael J Malloy, Ramaish Thangamani, Dorota Gertig, Kelly T Drennan, C David Wrede, Marion Saville, Michael Quinn

Journal article  |  2019  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country

Louiza S Velentzis, Michael Caruana, Kate T Simms, Jie-Bin Lew, Ju-Fang Shi, Marion Saville, Megan A Smith, Sarah J Lord, Jeffrey Tan, Deborah Bateson, Michael Quinn, Karen Canfell

Journal article  |  2017  |  International Journal of Cancer

HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples

Alyssa M Cornall, Marin Poljak, Suzanne M Garland, Samuel Phillips, Dorothy A Machalek, Jeffrey H Tan, Michael A Quinn, Sepehr N Tabrizi

Journal article  |  2017  |  Papillomavirus Research

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

Karen Canfell, Michael Caruana, Val Gebski, Jessica Darlington-Brown, Stella Heley, Julia Brotherton, Dorota Gertig, Chloe J Jennett, Annabelle Farnsworth, Jeffrey Tan, C David Wrede, Philip E Castle, Marion Saville

Journal article  |  2017  |  PLOS Medicine

Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

AM Cornall, M Poljak, SM Garland, S Phillips, JH Tan, DA Machalek, MA Quinn, SN Tabrizi

Journal article  |  2017  |  European Journal of Clinical Microbiology & Infectious Diseases

Findings and Outcomes in a Prevaccination Cohort of Women Younger Than 25 Years Attending a Tertiary Colposcopy Service

Yasmin L Jayasinghe, Rani Bhat, Michael Quinn, C David H Wrede, Jeffrey HJ Tan

Journal article  |  2016  |  Journal of Lower Genital Tract Disease

Clinicians' attitude towards changes in Australian National Cervical Screening Program

Desiree Yap, Xinyu Liang, Suzanne M Garland, Stefanie Hartley, Alexandra Gorelik, Gina Ogilvie, Jeffrey Tan, C David H Wrede, Yasmin Jayasinghe

Journal article  |  2016  |  Journal of Clinical Virology

Evaluation of p16(INK4a) immunostaining for the detection of high-grade changes in cervical cytology

Sepehr N Tabrizi, Sarah E Tan, Christina von Knebel Doeberitz, Jeffery Tan, Michael A Quinn, Suzanne M Garland

Journal article  |  2015  |  Pathology

Comparison of the Roche Cobas (R) 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia

Samuel Phillips, Suzanne M Garland, Jeffery H Tan, Michael A Quinn, Sepehr N Tabrizi

Journal article  |  2015  |  Journal of Clinical Virology

Hybrid Capture II Testing for High-Risk Human Papillomavirus DNA in the Follow-up of Women Treated for High-Grade Cervical Intraepithelial Neoplasia

Jeffrey HJ Tan, Suzanne M Garland, Sepehr N Tabrizi, Elya E Moore, Jennifer A Danielewski, Michael A Quinn

Journal article  |  2013  |  Journal of Lower Genital Tract Disease

Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)

Elisa J Young, Sepehr N Tabrizi, Julia ML Brotherton, John D Wark, Jan Pyman, Marion Saville, C David Wrede, Yasmin Jayasinghe, Jeffrey Tan, Dorota M Gertig, Marian Pitts, Suzanne M Garland

Journal article  |  2013  |  BMC CANCER

Expenditure and resource utilisation for cervical screening in Australia

Jie-Bin Lew, Kirsten Howard, Dorota Gertig, Megan Smith, Mark Clements, Carolyn Nickson, Ju-Fang Shi, Suzanne Dyer, Sarah Lord, Prudence Creighton, Yoon-Jung Kang, Jeffrey Tan, Karen Canfell

Journal article  |  2012  |  BMC Health Services Research

New technologies and advances in colposcopic assessment

Jeffrey HJ Tan, C David H Wrede

Journal article  |  2011  |  Best Practice and Research in Clinical Obstetrics and Gynaecology

Clearance of Human Papillomavirus in Women Treated for Cervical Dysplasia

Elya E Moore, Jennifer A Danielewski, Suzanne M Garland, Jeffrey Tan, Michael A Quinn, Matthew P Stevens, Sepehr N Tabrizi

Journal article  |  2011  |  Obstetrics and Gynecology

Should liquid-based cytology be performed prior to colposcopy? A comparison of the accuracy, unsatisfactory rates and cost in a tertiary referral setting

Donald Angstetra, Thomas Tait, Jeffrey Tan, Ian Symonds

Journal article  |  2009  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Detection of cervical intraepithelial neoplasia in vivo using confocal endomicroscopy

J Tan, MA Quinn, JM Pyman, PM Delaney, WJ McLaren

Journal article  |  2009  |  BJOG

Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia

Alice Huang, Michael Quinn, Jeffrey Tan

Journal article  |  2009  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

HPV Genotype Prevalence in Women With Abnormal Pap Smears in Melbourne, Australia

Matthew P Stevens, Suzanne M Garland, Jeffrey H Tan, Michael A Quinn, Rodney W Petersen, Sepehr N Tabrizi

Journal article  |  2009  |  Journal of Medical Virology

Does experience in colposcopy improve identification of high grade abnormalities?

Ruud L Bekkers, Hedwig P van de Nieuwenhof, Deborah E Neesham, Jan H Hendriks, Jeff Tan, Michael A Quinn

Journal article  |  2008  |  European Journal of Obstetrics & Gynecology and Reproductive Biology

"I want the one for older women" - extending the human papillomavirus vaccine population base

J TAN, M QUINN

Journal article  |  2008  |  Medical Journal of Australia

Comparison of the digene hybrid capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal pap smear results

Matthew P Stevens, Suzanne M Garland, Elice Rudland, Jeffrey Tan, Michael A Quinn, Sepehr N Tabrizi

Journal article  |  2007  |  Journal of Clinical Microbiology

Is colposcopy needed following laser ablation for dysplasia?

Li Jin, Jeffrey Tan, Derrick Thompson, Deborah Neesham, Michael Quinn

Journal article  |  2006  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Persistent trophoblast disease following partial molar pregnancy

S Wiesma, L Kerkmeijer, R Bekkers, J Pyman, J Tan, M Quinn

Journal article  |  2006  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Guidelines following hydatidiform mole: A reappraisal

S Wiesma, L Kerkmeijer, R Bekkers, J Pyman, J Tan, M Quinn

Journal article  |  2006  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Should the Pap smear be repeated at the first colposcopy visit?

G Dolman, J Tan, M Quinn

Journal article  |  2005  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Demographic variables routinely collected at colposcopic examination do not predict who will default from conservative management of cervical intraepithelial neoplasia I

JA Quinlivan, RW Petersen, L Gani, J Tan

Journal article  |  2005  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Women with low-grade abnormalities on Pap smear should be referred for colposcopy

A Fairman, J Tan, M Quinn

Journal article  |  2004  |  Australian and New Zealand Journal of Obstetrics and Gynaecology